Clinical trial

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

NCT03891394

Study summary

ClinicalTrials.gov

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Human epididymis protein 4 Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-04-01

PhaseN/A

Conditions

Preeclampsiaverified · MONDO: preeclampsia

Interventions

Human epididymis protein 4DIAGNOSTIC_TEST

Sponsors & collaborators

Ain Shams Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03891394 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.